Drummond Rebecca A, Desai Jigar V, Hsu Amy P, Oikonomou Vasileios, Vinh Donald C, Acklin Joshua A, Abers Michael S, Walkiewicz Magdalena A, Anzick Sarah L, Swamydas Muthulekha, Vautier Simon, Natarajan Mukil, Oler Andrew J, Yamanaka Daisuke, Mayer-Barber Katrin D, Iwakura Yoichiro, Bianchi David, Driscoll Brian, Hauck Ken, Kline Ahnika, Viall Nicholas Sp, Zerbe Christa S, Ferré Elise Mn, Schmitt Monica M, DiMaggio Tom, Pittaluga Stefania, Butman John A, Zelazny Adrian M, Shea Yvonne R, Arias Cesar A, Ashbaugh Cameron, Mahmood Maryam, Temesgen Zelalem, Theofiles Alexander G, Nigo Masayuki, Moudgal Varsha, Bloch Karen C, Kelly Sean G, Whitworth M Suzanne, Rao Ganesh, Whitener Cindy J, Mafi Neema, Gea-Banacloche Juan, Kenyon Lawrence C, Miller William R, Boggian Katia, Gilbert Andrea, Sincock Matthew, Freeman Alexandra F, Bennett John E, Hasbun Rodrigo, Mikelis Constantinos M, Kwon-Chung Kyung J, Belkaid Yasmine, Brown Gordon D, Lim Jean K, Kuhns Douglas B, Holland Steven M, Lionakis Michail S
Fungal Pathogenesis Section and.
Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
J Clin Invest. 2022 Nov 15;132(22):e159348. doi: 10.1172/JCI159348.
Subcutaneous phaeohyphomycosis typically affects immunocompetent individuals following traumatic inoculation. Severe or disseminated infection can occur in CARD9 deficiency or after transplantation, but the mechanisms protecting against phaeohyphomycosis remain unclear. We evaluated a patient with progressive, refractory Corynespora cassiicola phaeohyphomycosis and found that he carried biallelic deleterious mutations in CLEC7A encoding the CARD9-coupled, β-glucan-binding receptor, Dectin-1. The patient's PBMCs failed to produce TNF-α and IL-1β in response to β-glucan and/or C. cassiicola. To confirm the cellular and molecular requirements for immunity against C. cassiicola, we developed a mouse model of this infection. Mouse macrophages required Dectin-1 and CARD9 for IL-1β and TNF-α production, which enhanced fungal killing in an interdependent manner. Deficiency of either Dectin-1 or CARD9 was associated with more severe fungal disease, recapitulating the human observation. Because these data implicated impaired Dectin-1 responses in susceptibility to phaeohyphomycosis, we evaluated 17 additional unrelated patients with severe forms of the infection. We found that 12 out of 17 carried deleterious CLEC7A mutations associated with an altered Dectin-1 extracellular C-terminal domain and impaired Dectin-1-dependent cytokine production. Thus, we show that Dectin-1 and CARD9 promote protective TNF-α- and IL-1β-mediated macrophage defense against C. cassiicola. More broadly, we demonstrate that human Dectin-1 deficiency may contribute to susceptibility to severe phaeohyphomycosis by certain dematiaceous fungi.
皮下暗色丝孢霉病通常在创伤接种后影响免疫功能正常的个体。严重或播散性感染可发生在CARD9缺陷患者或移植后,但抵御暗色丝孢霉病的机制仍不清楚。我们评估了一名患有进行性、难治性卡西棒孢暗色丝孢霉病的患者,发现他在编码与CARD9偶联的β-葡聚糖结合受体Dectin-1的CLEC7A基因中携带双等位基因有害突变。该患者的外周血单核细胞(PBMC)对β-葡聚糖和/或卡西棒孢菌无反应,无法产生肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL-1β)。为了确定抗卡西棒孢菌免疫的细胞和分子需求,我们建立了这种感染的小鼠模型。小鼠巨噬细胞产生IL-1β和TNF-α需要Dectin-1和CARD9,它们以相互依赖的方式增强真菌杀伤作用。Dectin-1或CARD9缺陷与更严重的真菌病相关,这与人类观察结果一致。由于这些数据表明Dectin-1反应受损与暗色丝孢霉病易感性有关,我们评估了另外17名患有严重感染形式的无关患者。我们发现,17名患者中有12名携带与Dectin-1细胞外C末端结构域改变和Dectin-1依赖性细胞因子产生受损相关的有害CLEC7A突变。因此,我们表明Dectin-1和CARD9促进了由TNF-α和IL-1β介导的巨噬细胞对卡西棒孢菌的保护性防御。更广泛地说,我们证明人类Dectin-1缺陷可能导致对某些暗色真菌引起的严重暗色丝孢霉病易感。